Vaylen vs HumeCare+ — Cost, protocol, and support compared
Quick verdict: Vaylen is the lower priced, pay-first compounded GLP-1 option with oral tablets and tirzepatide on one platform, while HumeCare+ bundles GLP-1 with glycine, B vitamins, body composition scans, and a money back promise. This article compares Vaylen vs HumeCare+ across pricing and billing, protocol and added supports, shipping and turnaround, refund and guarantee policies, and regulatory disclosures.
See Vaylen pricing and formats
Head to head summary: Vaylen vs HumeCare+
Vaylen emphasizes low monthly rates on prepaid 12 month plans, multiple formats including oral semaglutide and tirzepatide, and a full refund if a clinician does not approve your prescription. HumeCare+ positions a protocol that adds glycine, B6 and B12 for muscle support, monthly body composition scans, 24/7 clinician access, and a 10 percent or your money back promise over six months. Both use compounded medications and note that compounded products are not FDA evaluated.
Comparison table: five core criteria
| Criteria | Vaylen | HumeCare+ |
|---|---|---|
| Starting price | Semaglutide from $83.25/mo on 12 month plan or $224/mo month to month | Semaglutide from $199/mo; tirzepatide protocol from $299/mo |
| Billing model | Prepaid 12 month plans billed upfront; clinician review after payment | Subscription monthly; cancel anytime; promotional pricing noted |
| Protocol and extras | Compounded semaglutide injectable, oral tablet, and tirzepatide on one platform | GLP-1 plus glycine, B12, B6, body composition scans, app and 24/7 clinician access |
| Shipping and turnaround | Clinician review within 24 hours; free discreet shipping in 1 to 3 business days | Free next day delivery and monthly scans; app for tracking |
| Refunds and guarantees | Full refund of prepaid billing cycle if clinician declines to prescribe | 10 percent or your money back promise over six months; terms apply |
Pricing and billing model
Vaylen advertises headline rates as annualized prices on a 12 month plan billed upfront. Semaglutide injections are $83.25 per month on the 12 month program or $224 per month month to month. Oral semaglutide tablets are $99 per month prepaid or $249 month to month. Tirzepatide is listed at $149 per month on the 12 month plan or $299 month to month. By contrast, HumeCare+ lists semaglutide from $199 per month and its dual action tirzepatide protocol with B12 and glycine from $299 per month, and notes those prices reflect a promotional discount that may change. Vaylen requires prepayment before clinician review while HumeCare+ uses a monthly subscription model you can cancel anytime.
View HumeCare+ protocol and pricing
Protocol differences: medication alone versus scaffolded support
Vaylen offers three treatment formats on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide. Vaylen highlights the convenience of switching molecules or formats without changing providers and notes all offerings are compounded. HumeCare+ packages GLP-1 medication with glycine and vitamins B6 and B12 intended for muscle support and side effect relief, monthly body composition scans that track lean mass versus fat, and an app for tracking and clinician access. HumeCare+ frames its program as solving muscle loss and side effects that medication alone may not address and includes a money back promise if specific weight loss criteria are not met over six months, subject to their terms.
Shipping, clinician access, and turnaround
Vaylen states a clinician reviews your health form within 24 hours and offers free discreet shipping in 1 to 3 business days. Vaylen also advertises a $0 consultation fee and 24 7 care team messaging included in plans. HumeCare+ advertises free next day delivery, an app for medication tracking and food logging, and unlimited clinician access with a U.S. care team available 24 7.
Start with Vaylen if you want fast clinician review
Refunds, guarantees, and regulatory notes
Vaylen offers a full refund for the prepaid billing cycle if a clinician decides GLP-1 medication is not clinically appropriate. HumeCare+ offers a 10 percent or your money back promise over six months, with eligibility and documentation requirements noted in its terms. Both providers clearly state that their compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or quality. HumeCare+ also flags that headline results are internal and company reported, and that GLP-1 drugs carry serious risks.
Compare Vaylen formats and refund policy
Final take on Vaylen vs HumeCare+
In short, Vaylen vs HumeCare+ is a choice between lower prepaid headline pricing and multi format access at Vaylen, and a bundled clinical protocol focused on muscle support, tracking, and a money back promise at HumeCare+. Both use compounded GLP-1 medications and both require clinician approval to start treatment.
Choose Vaylen if you want the lowest effective monthly headline rate on a prepaid 12 month plan, access to both oral semaglutide and injectable options on one platform, rapid clinician review, and a published refund if a clinician declines to prescribe.
Choose HumeCare+ if you want a bundled protocol that adds glycine and B vitamins for muscle support and side-effect relief, monthly body composition scans to track lean mass, an app and 24 7 clinician access, and a 10 percent or your money back promise over six months.